{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:24:55Z","timestamp":1773296695433,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.pnpbp.2007.04.007","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T11:10:21Z","timestamp":1177153821000},"page":"1130-1138","source":"Crossref","is-referenced-by-count":34,"title":["Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia\u2014A biochemical and neurochemical study"],"prefix":"10.1016","volume":"31","author":[{"given":"Mahendra","family":"Bishnoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanwaljit","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrinivas K.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.04.007_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptics induced oral dyskinesia in rats, implications for tardive dyskinesia","volume":"65","author":"Andreassen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brainresbull.2004.09.001","article-title":"Effects of topiramate on oral dyskinesia induced by reserpine","volume":"64","author":"Araujo","year":"2005","journal-title":"Brain Res Bull"},{"issue":"5","key":"10.1016\/j.pnpbp.2007.04.007_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0197-0186(00)00108-X","article-title":"Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics","volume":"38","author":"Balijepalli","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-2999(98)00428-2","article-title":"Pharmacological properties of the GABA A receptor complex from brain regions of (hypoemotional) Roman high- and (hyperemotional) low-avoidance rats","volume":"354","author":"Bentareha","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2007.04.007_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1011171124603","article-title":"Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacuous chewing movements","volume":"15","author":"Bester","year":"2000","journal-title":"Metab Brain Dis"},{"issue":"1-3","key":"10.1016\/j.pnpbp.2007.04.007_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2006.09.010","article-title":"Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes","volume":"552","author":"Bishnoi","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib7","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/S0040-4020(01)87108-8","article-title":"New antioxidants incorporating indole and indolinechromophores","volume":"25","author":"Brown","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0278-5846(02)00344-5","article-title":"Ebselen attenuates reserpine induced orofacial dyskinesia and oxidative stress in rat striatum","volume":"27","author":"Burger","year":"2003","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.brainresbull.2004.09.006","article-title":"Effect of age on reserpine induced orofacial dyskinesia possible protection of diphenyl diselenide","volume":"64","author":"Burger","year":"2004","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.pnpbp.2007.04.007_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2004.10.038","article-title":"Acute reserpine and sub-chronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats","volume":"1031","author":"Burger","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","article-title":"Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain","volume":"81","author":"Burger","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pnpbp.2007.04.007_bib12","first-page":"A36","article-title":"Column chromatography analysis of brain tissue: an advanced laboratory exercise for neuroscience majors","volume":"3","author":"Church","year":"2005","journal-title":"J Undergrad Psychol Res"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib14","first-page":"125","article-title":"Neurotoxic effect of 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl (-pyridinium) (HP+), a major metabolite of haloperidol in the dopaminergic system in vitro and in vivo","volume":"12","author":"Fang","year":"1996","journal-title":"Biog Amines"},{"issue":"4","key":"10.1016\/j.pnpbp.2007.04.007_bib15","first-page":"435","article-title":"Zolpidem for antipsychotic-induced","volume":"35","author":"Farver","year":"2001","journal-title":"Parkinsonism"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0166-2236(84)80254-4","article-title":"Neurobiological substrates of tardive dyskinesia: the GABA hypothesis","volume":"7","author":"Fibiger","year":"1984","journal-title":"Trends Neurosci"},{"issue":"12","key":"10.1016\/j.pnpbp.2007.04.007_bib17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/10715760400017343","article-title":"Antioxidant activity and neuroprotective effects of zolpidem and several synthesis intermediates","volume":"38","author":"Garcia-Santos","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","article-title":"Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis","volume":"309","author":"Gunne","year":"1984","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.pnpbp.2007.04.007_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-4328(00)00156-X","article-title":"Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatment","volume":"111","author":"Harvey","year":"2000","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2007.04.007_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0361-9230(03)00143-6","article-title":"Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia","volume":"61","author":"Harvey","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02537058","article-title":"Nitric oxide an inhibitor of lipid peroxidation by lipoxygenase, cyclooxygenase and hemoglobin","volume":"27","author":"Kanner","year":"1992","journal-title":"Lipids"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10715769109049143","article-title":"Reactivity of indole derivatives towards oxygenated radicals","volume":"15","author":"Lissi","year":"1991","journal-title":"Free Radic Res Commun"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen radicals and neuropsychiatric illness: some speculations","volume":"48","author":"Lohr","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurements with the Folin\u2013phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib28","series-title":"Methods in enzymatic analysis","article-title":"Catalase spectrophotometric method","author":"Luck","year":"1963"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-4165(02)00527-5","article-title":"Protection against oxidative protein damage induced by metal catalyzed reaction or alkylperoxylradicals: comparative effects of melatonin and other antioxidants","volume":"1620","author":"Mayo","year":"2003","journal-title":"Biochem Biophys Acta"},{"issue":"2","key":"10.1016\/j.pnpbp.2007.04.007_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0704717","article-title":"Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms","volume":"136","author":"Naidu","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib31","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0028-3908(03)00101-1","article-title":"Quercetin, a bioflavonoid attenuated haloperidol induced orofacial dyskinesia","volume":"44","author":"Naidu","year":"2003","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2007.04.007_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ptr.1823","article-title":"Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction","volume":"20","author":"Naidu","year":"2006","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2007.04.007_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00008877-200305000-00010","article-title":"Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine","volume":"14","author":"Nel","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1471-4159.1987.tb00977.x","article-title":"Auto radiographic localization of [3H] zolpidem binding sites in the rat CNS: comparison with the distribution of [3H] flunitrazepam binding sites","volume":"49","author":"Niddam","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib35","doi-asserted-by":"crossref","first-page":"31891","DOI":"10.1074\/jbc.274.45.31891","article-title":"Na (\u00fe)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal","volume":"274","author":"O'Kane","year":"1999","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pnpbp.2007.04.007_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-4347(94)00490-V","article-title":"Automated analysis of urinary catecholamines by high-performance liquid chromatography and on-line sample pretreatment","volume":"664","author":"Pastoris","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2004.11.014","article-title":"Effects of GABAergic drugs on reserpine-induced oral dyskinesia","volume":"160","author":"Peixoto","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-079X.2002.01873.x","article-title":"Melatonin's unique radical scavenging properties-roles of its functional substituents as revealed by a comparison with its structural analogs","volume":"33","author":"Poeggeler","year":"2002","journal-title":"J Pineal Res"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)02455-6","article-title":"Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors","volume":"904","author":"Raghavendra","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0304-3940(91)90477-B","article-title":"Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride","volume":"129","author":"See","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib41","first-page":"1137","article-title":"Oxidative stress and thiol modification induced by chronic administration of haloperidol","volume":"265","author":"Shivakumar","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pnpbp.2007.04.007_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(03)02124-1","article-title":"Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia","volume":"477","author":"Singh","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib43","first-page":"CD000203","article-title":"Gamma-amino butyric acid agonist's for neuroleptic-induced tardive dyskinesia","volume":"18","author":"Soares","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1568026013394741","article-title":"Oxytosis: a novel form of programmed cell death","volume":"1","author":"Tan","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(98)01230-9","article-title":"Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?","volume":"19","author":"Trotti","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers of glutamatergic transmission and oxidative stress associated with tardive dyskinesia","volume":"155","author":"Tsai","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem J"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0076-6879(99)01105-2","article-title":"Antioxidant effects of nitric oxide","volume":"301","author":"Wink","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pnpbp.2007.04.007_bib49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1006948921855","article-title":"Glutamate receptor requirement for neuronal death from an oxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens","volume":"19","author":"Zaulyanov","year":"1999","journal-title":"Cell Mol Neurobiol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607001388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607001388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:45:43Z","timestamp":1628797543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607001388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0278584607001388"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.04.007","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}